APA (7th ed.) Citation

Pokorny, T., Preller, K. H., Kraehenmann, R., & Vollenweider, F. X. (2016). Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. European neuropsychopharmacology, 26(4), 756-766. https://doi.org/10.1016/j.euroneuro.2016.01.005

Chicago Style (17th ed.) Citation

Pokorny, Thomas, Katrin H. Preller, Rainer Kraehenmann, and Franz X. Vollenweider. "Modulatory Effect of the 5-HT1A Agonist Buspirone and the Mixed Non-hallucinogenic 5-HT1A/2A Agonist Ergotamine on Psilocybin-induced Psychedelic Experience." European Neuropsychopharmacology 26, no. 4 (2016): 756-766. https://doi.org/10.1016/j.euroneuro.2016.01.005.

MLA (9th ed.) Citation

Pokorny, Thomas, et al. "Modulatory Effect of the 5-HT1A Agonist Buspirone and the Mixed Non-hallucinogenic 5-HT1A/2A Agonist Ergotamine on Psilocybin-induced Psychedelic Experience." European Neuropsychopharmacology, vol. 26, no. 4, 2016, pp. 756-766, https://doi.org/10.1016/j.euroneuro.2016.01.005.